Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human RLN2 Protein, N-His

Catalog #:   YHC06401 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: P04090
Protein length: Val23-Cys185
Overview

Catalog No.

YHC06401

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Val23-Cys185

Predicted molecular weight

20.75 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

P04090

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Prorelaxin H2, RLN2

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant Human RLN2 protein
References

The Discovery of C7-Substituted Norbornyl Bisamides as RXFP1 Small Molecule Agonists., PMID:40434342

Relaxin-2 Ameliorates Spinal Cord Injury by Inhibiting Microglia Activation., PMID:40392018

Relaxin 2 Suppresses Tumor Growth in Esophageal Squamous Cell Carcinoma EC9706 Cells Through Modulation of the STAT Signaling Pathway., PMID:40343386

Relaxin-2 mitigates the interaction between monocytes and endothelial cells by suppressing Egr-1., PMID:40192193

A novel long-acting relaxin-2 fusion, AZD3427, improves cardiac performance in non-human primates with cardiac dysfunction., PMID:40037346

Relationship between relaxin-2 levels in serum and mode of conception in twin gestations: A prospective cohort study., PMID:39716018

Role of Relaxin Signaling in Cancer: A Review., PMID:39547477

C1QTNF Related protein 8 (CTRP8) is a marker of myeloid derived innate immune cell populations in the human breast cancer microenvironment., PMID:39542181

Engineering and Characterization of a Long-Half-Life Relaxin Receptor RXFP1 Agonist., PMID:39134056

Prognostic association of circulating relaxin-2 in acute heart failure., PMID:39002802

Immune-related gene methylation prognostic instrument for stratification and targeted treatment of ovarian cancer patients toward advanced 3PM approach., PMID:38841623

Relaxin-2 is a novel biomarker for differentiated thyroid carcinoma in humans., PMID:38815632

Identification and Quantification of Human Relaxin Proteins by Immunoaffinity-Mass Spectrometry., PMID:38739617

Significance of plasma relaxin-2 levels in patients with primary hypertension and type 2 diabetes mellitus., PMID:38451351

Programmed Death-Ligand (PD-L1), Epidermal Growth Factor (EGF), Relaxin, and Matrix Metalloproteinase-3 (MMP3): Potential Biomarkers of Malignancy in Canine Mammary Neoplasia., PMID:38256245

Specific expression and blood kinetics for relaxin 2, lipocalin 2, and tissue factor pathway inhibitor 2 at the canine placenta and pregnant bloods., PMID:38057091

Expression and Prognostic Value of m6A RNA Methylation-Related Genes in Thyroid Cancer., PMID:38033847

Identification and validation of molecular subtypes and a 9-gene risk model for breast cancer., PMID:37747033

Cardiovascular effects of relaxin-2: therapeutic potential and future perspectives., PMID:37721595

The role of breast milk beta-endorphin and relaxin-2 on infant colic., PMID:37142649

The dual and multifaceted role of relaxin-2 in cancer., PMID:36947362

Human C1q Tumor Necrosis Factor 8 (CTRP8) defines a novel tryptase+ mast cell subpopulation in the prostate cancer microenvironment., PMID:36921737

Tumor-activated neutrophils promote metastasis in breast cancer via the G-CSF-RLN2-MMP-9 axis., PMID:36801950

Relaxin-2 plasma levels in atrial fibrillation are linked to inflammation and oxidative stress markers., PMID:36566255

Relaxin-2 during pregnancy according to glycemia, continence status, and pelvic floor muscle function., PMID:35657397

A bibliometric review of peripartum cardiomyopathy compared to other cardiomyopathies using artificial intelligence and machine learning., PMID:35340600

Structural Insights into the Unique Modes of Relaxin-Binding and Tethered-Agonist Mediated Activation of RXFP1 and RXFP2., PMID:34454945

An organ-on-a-chip model for pre-clinical drug evaluation in progressive non-genetic cardiomyopathy., PMID:34216608

Identification of Potent and Long-Acting Single-Chain Peptide Mimetics of Human Relaxin-2 for Cardiovascular Diseases., PMID:33555858

Rh-relaxin-2 attenuates degranulation of mast cells by inhibiting NF-κB through PI3K-AKT/TNFAIP3 pathway in an experimental germinal matrix hemorrhage rat model., PMID:32859236

Recombinant human H2 relaxin (serelaxin) as a cardiovascular drug: aiming at the right target., PMID:32360533

Tissue-specific relaxin-2 is differentially associated with the presence/size of an arterial aneurysm and the severity of atherosclerotic disease in humans., PMID:32024951

Administration study of recombinant human relaxin-2 in horse for doping control purpose., PMID:31726484

Intraarticular injection of relaxin-2 alleviates shoulder arthrofibrosis., PMID:31160441

Human recombinant relaxin-2 does not attenuate hypertension or renal injury but exacerbates vascular dysfunction in a female mouse model of SLE., PMID:31125285

Healthy Donors Exhibit a CD4 T Cell Repertoire Specific to the Immunogenic Human Hormone H2-Relaxin before Injection., PMID:31101669

The Role of Relaxin-2 in Tissue Remodeling of Chronic Rhinosinusitis With Nasal Polyps., PMID:31007042

Human relaxin-2 attenuates hepatic steatosis and fibrosis in mice with non-alcoholic fatty liver disease., PMID:30918325

Emerging roles for the relaxin/RXFP1 system in cancer therapy., PMID:30763603

Commercial immunoassays for human relaxin-2., PMID:30633956

Relaxin in liver transplantation: A personal perspective., PMID:30550815

Nano-targeted relaxin impairs fibrosis and tumor growth in pancreatic cancer and improves the efficacy of gemcitabine in vivo., PMID:30287265

Relaxin 2/RXFP1 Signaling Induces Cell Invasion via the β-Catenin Pathway in Endometrial Cancer., PMID:30126180

Relaxin-2 therapy reverses radiation-induced fibrosis and restores bladder function in mice., PMID:29806709

The subset of patients with acute heart failure able to secrete relaxin-2 at pregnancy concentrations could have a longer survival: a pilot study., PMID:29716428

Chromatin Immunoprecipitation and DNA Sequencing Identified a LIMS1/ILK Pathway Regulated by LMO1 in Neuroblastoma., PMID:29695398

Associations between serum relaxin 2, aneurysm formation/size and severity of atherosclerosis: a preliminary prospective analysis., PMID:29565035

Serum relaxin-2 as a novel biomarker for prostate cancer., PMID:29513121

Optimizing Hypertensive Acute Heart Failure Management with Afterload Reduction., PMID:29478124

Decreased Serum Relaxin-2 Is Correlated with Impaired Islet β-Cell Function in Patients with Unstable Angina and Abnormal Glucose Metabolism., PMID:29445056

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human RLN2 Protein, N-His [YHC06401]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only